Elias Obeid

1.5k total citations
41 papers, 671 citations indexed

About

Elias Obeid is a scholar working on Oncology, Cancer Research and Genetics. According to data from OpenAlex, Elias Obeid has authored 41 papers receiving a total of 671 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Oncology, 17 papers in Cancer Research and 16 papers in Genetics. Recurrent topics in Elias Obeid's work include BRCA gene mutations in cancer (13 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Genomics and Diagnostics (9 papers). Elias Obeid is often cited by papers focused on BRCA gene mutations in cancer (13 papers), Breast Cancer Treatment Studies (9 papers) and Cancer Genomics and Diagnostics (9 papers). Elias Obeid collaborates with scholars based in United States, Poland and Taiwan. Elias Obeid's co-authors include Olufunmilayo I. Olopade, Rita Nanda, Yang‐Xin Fu, Suzanne D. Conzen, Michael J. Hall, Veda N. Giri, Kaylene Ready, Diane D. Liu, Jennifer K. Litton and Amal Melhem‐Bertrandt and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Elias Obeid

39 papers receiving 663 citations

Peers

Countries citing papers authored by Elias Obeid

Since Specialization

Citations

This map shows the geographic impact of Elias Obeid's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elias Obeid with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elias Obeid more than expected).

Fields of papers citing papers by Elias Obeid

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elias Obeid. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elias Obeid. The network helps show where Elias Obeid may publish in the future.

Co-authorship network of co-authors of Elias Obeid

This figure shows the co-authorship network connecting the top 25 collaborators of Elias Obeid. A scholar is included among the top collaborators of Elias Obeid based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elias Obeid. Elias Obeid is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Meal timing and risk of metabolic syndrome in the prospective French NutriNet-Santé biobank 2024 ·European Journal of Public Health ·Elias Obeid, (unknown), Khaled Ezzedine, (unknown), Sandrine Péneau, (unknown), Mélanie Deschasaux, Mathilde Touvier, Valentina A. Andreeva, Bernard Srour	1
2	Genetic Variants and Tumor Immune Microenvironment: Clues for Targeted Therapies in Inflammatory Breast Cancer (IBC) 2021 ·International Journal of Molecular Sciences ·Yulan Gong, (unknown), Maria F. Arisi, Lorenzo Gerratana, (unknown), Michael Slifker, Jianming Pei, Kathy Q. Cai, (unknown), Elias Obeid, (unknown), Christopher Sebastiano, Eric A. Ross, Katherine Alpaugh, Massimo Cristofanilli, Sandra V. Fernandez	1
3	Genetic Contribution to Metastatic Prostate Cancer 2021 ·Urologic Clinics of North America ·Alexandra Sokolova, Elias Obeid, Heather H. Cheng	2
4	Genetic Variants Detected Using Cell-Free DNA from Blood and Tumor Samples in Patients with Inflammatory Breast Cancer 2020 ·International Journal of Molecular Sciences ·(unknown), (unknown), Michael Slifker, Jianming Pei, (unknown), Jacqueline Talarchek, Elias Obeid, Donald Baldwin, Yulan Gong, Eric A. Ross, Massimo Cristofanilli, R. Katherine Alpaugh, Sandra V. Fernandez	12
5	PCN314 REAL-WORLD PATIENT DEMOGRAPHICS, TREATMENT PATTERNS AND HEALTHCARE RESOURCE UTILIZATION (HRU) AMONG HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2 NEGATIVE (HER2-) ADVANCED BREAST CANCER (ABC) PATIENTS WITH BRCA1/2 MUTATIONS (BRCA1/2MUT) 2020 ·Value in Health ·Rohan Parikh, (unknown), Elizabeth Esterberg, Bhakti Arondekar, (unknown), (unknown), Elias Obeid	1
6	The effect of neighborhood social environment on prostate cancer development in black and white men at high risk for prostate cancer 2020 ·PLoS ONE ·Shannon M. Lynch, Elizabeth A. Handorf, Kristen A. Sorice, Elizabeth Blackman, (unknown), Veda N. Giri, Elias Obeid, Camille Ragin, Mary Daly	11
7	Physical activity assessment among men undergoing genetic counseling for inherited prostate cancer: a teachable moment for improved survivorship 2020 ·Supportive Care in Cancer ·(unknown), Brandy‐Joe Milliron, Elizabeth Sinclair, Elias Obeid, (unknown), (unknown), (unknown), Meghan L. Butryn, Veda N. Giri	3
8	Hematologic toxicity in BRCA1 and BRCA2 mutation carriers during chemotherapy: A retrospective matched cohort study 2019 ·Cancer Medicine ·(unknown), (unknown), (unknown), Donald Hedeker, (unknown), Sarah M. Nielsen, (unknown), (unknown), (unknown), Mary B. Daly, Anosheh Afghahi, Olufunmilayo I. Olopade, Peter J. Hulick, Elena Shagisultanova, Dezheng Huo, Elias Obeid, Jane Churpek	7
9	Time to Surgery and the Impact of Delay in the Non-Neoadjuvant Setting on Triple-Negative Breast Cancers and Other Phenotypes 2019 ·Annals of Surgical Oncology ·(unknown), (unknown), Elias Obeid, J.M. Daly, Elin R. Sigurdson, Elizabeth A. Handorf, (unknown), (unknown), Richard J. Bleicher	33
10	Patterns of Care and Efficacy of Chemotherapy and Radiotherapy in Skin-Involved Breast Cancers of All Sizes 2019 ·Clinical Breast Cancer ·(unknown), (unknown), (unknown), Elin R. Sigurdson, Elizabeth A. Handorf, J.M. Daly, (unknown), Elias Obeid, S.B. Hayes, Richard J. Bleicher	1
11	Racial Disparities in the Molecular Landscape of Cancer 2018 ·Anticancer Research ·Elisabeth I. Heath, Filipa Lynce, Joanne Xiu, (unknown), Sandeep K. Reddy, Elias Obeid, Stephen V. Liu, Aliccia Bollig‐Fischer, Duška Šeparović, Ari M. Vanderwalde	45
12	Understanding of multigene test results among males undergoing germline testing for inherited prostate cancer: Implications for genetic counseling 2018 ·The Prostate ·Veda N. Giri, Elias Obeid, Sarah Hegarty, (unknown), (unknown), Colette Hyatt, Carolyn Y. Fang, Amy Leader	16
13	Tumor mutational load in gynecological and breast cancer. 2017 ·Journal of Clinical Oncology ·Filipa Lynce, Joanne Xiu, Elias Obeid, Antoinette R. Tan, Zoran Gatalica, Claudine Isaacs, Paula R. Pohlmann	2
14	A randomized phase I trial of nanoparticle albumin-bound paclitaxel with or without mifepristone for advanced breast cancer 2016 ·SpringerPlus ·Rita Nanda, Erica Stringer-Reasor, (unknown), Masha Kocherginsky, (unknown), (unknown), Philip C. Hoffman, Elias Obeid, Douglas E. Merkel, Galina Khramtsova, Maxwell N. Skor, Thomas Krausz, Ronald Cohen, Mark J. Ratain, Gini F. Fleming, Suzanne D. Conzen	30
15	Genetic testing for hereditary cancer predisposition: BRCA1/2, Lynch syndrome, and beyond 2016 ·Gynecologic Oncology ·Michael J. Hall, Elias Obeid, (unknown), Gina Mantia-Smaldone, Andrea Forman, Mary B. Daly	34
16	Effects of a randomized trial comparing standard and enhanced counseling for men at high risk of prostate cancer as a function of race and monitoring style 2016 ·Journal of Health Psychology ·Pagona Roussi, Suzanne M. Miller, Veda N. Giri, Elias Obeid, Kuang‐Yi Wen, Erin K. Tagai, John Scarpato, (unknown), (unknown)	7
17	Lessons Learned from Implementing a Prostate Cancer Risk Assessment Program for Underserved High-Risk Men in the Community: the Prostate REACH Project 2015 ·Journal of Cancer Education ·Linda Fleisher, Stacy N. Davis, (unknown), (unknown), (unknown), Evelyn González, (unknown), (unknown), (unknown), Elias Obeid, Veda N. Giri	6
18	Comparison of Adjuvant Radiation Therapy Alone Versus Radiation Therapy and Endocrine Therapy in Elderly Women With Early-Stage, Hormone Receptor-Positive Breast Cancer Treated With Breast-Conserving Surgery 2015 ·Clinical Breast Cancer ·Colin T. Murphy, Tianyu Li, Lora S. Wang, Elias Obeid, Richard J. Bleicher, (unknown), (unknown), S.B. Hayes, Stephanie E. Weiss, Penny R. Anderson	20
19	Triple Negative Breast Cancer in BRCA1 Mutation Carriers With a Complete Radiologic Response to Neoadjuvant Paclitaxel: A Case Report 2014 ·Clinical Breast Cancer ·Monika L. Burness, Elias Obeid, Olufunmilayo I. Olopade	4
20	The role of tumor-associated macrophages in breast cancer progression 2013 ·International Journal of Oncology ·Elias Obeid, Rita Nanda, Yang‐Xin Fu, Olufunmilayo I. Olopade	169

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact